Herpes simplex virus turns off the TAP to evade host immunity
- PMID: 7760935
- DOI: 10.1038/375411a0
Herpes simplex virus turns off the TAP to evade host immunity
Abstract
Many viruses have evolved mechanisms to avoid detection by the host immune system. Herpes simplex virus (HSV) expresses an immediate early protein, ICP47, which blocks presentation of viral peptides to MHC class I-restricted cells. The properties of the newly synthesized class I molecules in HSV-infected cells resemble those of cell lines deficient in the transporter associated with antigen processing (TAP) in that class I molecules are retained in the endoplasmic reticulum, and the heavy chain and beta 2-microglobulin subunits dissociate in detergent extracts but the complex can be stabilized by peptides. We show here that ICP47 binds to TAP and prevents peptide translocation into the endoplasmic reticulum.
Similar articles
-
A viral inhibitor of peptide transporters for antigen presentation.Nature. 1995 Jun 1;375(6530):415-8. doi: 10.1038/375415a0. Nature. 1995. PMID: 7760936
-
Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.EMBO J. 1996 Jul 1;15(13):3247-55. EMBO J. 1996. PMID: 8670825 Free PMC article.
-
Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.Int J Cancer. 2012 Sep 1;131(5):E659-69. doi: 10.1002/ijc.27362. Epub 2012 Jan 3. Int J Cancer. 2012. PMID: 22116674
-
Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses.Curr Top Microbiol Immunol. 2002;269:57-74. doi: 10.1007/978-3-642-59421-2_4. Curr Top Microbiol Immunol. 2002. PMID: 12224516 Review.
-
The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing.Physiology (Bethesda). 2004 Aug;19:216-24. doi: 10.1152/physiol.00002.2004. Physiology (Bethesda). 2004. PMID: 15304636 Review.
Cited by
-
Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector.Front Immunol. 2024 Sep 12;15:1445387. doi: 10.3389/fimmu.2024.1445387. eCollection 2024. Front Immunol. 2024. PMID: 39328406 Free PMC article. Review.
-
The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Clin Dev Immunol. 2013;2013:369172. doi: 10.1155/2013/369172. Epub 2013 Mar 31. Clin Dev Immunol. 2013. PMID: 23606868 Free PMC article. Review.
-
Developments in herpes simplex virus vaccines: old problems and new challenges.Folia Microbiol (Praha). 2006;51(2):67-85. doi: 10.1007/BF02932160. Folia Microbiol (Praha). 2006. PMID: 16821715 Review.
-
ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice.J Neurovirol. 2006 Dec;12(6):420-7. doi: 10.1080/13550280601009546. J Neurovirol. 2006. PMID: 17162658
-
Modulation of HLA-G expression in human neural cells after neurotropic viral infections.J Virol. 2005 Dec;79(24):15226-37. doi: 10.1128/JVI.79.24.15226-15237.2005. J Virol. 2005. PMID: 16306594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous